Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

BACKGROUND: Lasmiditan demonstrated superiority to placebo in the acute treatment of migraine in adults with moderate/severe migraine disability in two similarly designed Phase 3 trials, SAMURAI and SPARTAN. Post-hoc integrated analyses evaluated the efficacy of lasmiditan in patients who reported a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cephalalgia
Hoofdauteurs: Knievel, Kerry, Buchanan, Andrew S, Lombard, Louise, Baygani, Simin, Raskin, Joel, Krege, John H, Loo, Li Shen, Komori, Mika, Tobin, Joshua
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6950889/
https://ncbi.nlm.nih.gov/pubmed/31744319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419889350
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items